Cargando…

Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts

BACKGROUND: Toxoplasma gondii has been shown to trigger strong cellular immune responses to heterologous antigens expressed by the parasite in the inbred mouse model [1]. We studied the immune response induced by T. gondii as an effective vaccine vector in chickens and rabbits. RESULTS: T. gondii RH...

Descripción completa

Detalles Bibliográficos
Autores principales: Zou, Jun, Huang, Xiao-Xi, Yin, Guang-Wen, Ding, Ye, Liu, Xian-Yong, Wang, Heng, Chen, Qi-Jun, Suo, Xun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177786/
https://www.ncbi.nlm.nih.gov/pubmed/21871123
http://dx.doi.org/10.1186/1756-3305-4-168
_version_ 1782212326977437696
author Zou, Jun
Huang, Xiao-Xi
Yin, Guang-Wen
Ding, Ye
Liu, Xian-Yong
Wang, Heng
Chen, Qi-Jun
Suo, Xun
author_facet Zou, Jun
Huang, Xiao-Xi
Yin, Guang-Wen
Ding, Ye
Liu, Xian-Yong
Wang, Heng
Chen, Qi-Jun
Suo, Xun
author_sort Zou, Jun
collection PubMed
description BACKGROUND: Toxoplasma gondii has been shown to trigger strong cellular immune responses to heterologous antigens expressed by the parasite in the inbred mouse model [1]. We studied the immune response induced by T. gondii as an effective vaccine vector in chickens and rabbits. RESULTS: T. gondii RH strain was engineered to express the yellow fluorescent protein (YFP) in the cytoplasm. A subcutaneous injection of the transgenic T. gondii YFP in chickens afforded partial protection against the infection of transgenic E. tenella YFP. T. gondii YFP induced low levels of antibodies to YFP in chickens, suggesting that YFP specific cellular immune response was probably responsible for the protective immunity against E. tenella YFP infection. The measurement of T-cell response and IFN-γ production further confirmed that YFP specific Th1 mediated immune response was induced by T. gondii YFP in immunized chickens. The transgenic T. gondii stimulated significantly higher YFP specific IgG titers in rabbits than in chickens, suggesting greater immunogenicity in a T. gondii susceptible species than in a resistant species. Priming with T. gondii YFP and boosting with the recombinant YFP can induce a strong anti-YFP antibody response in both animal species. CONCLUSIONS: Our findings suggest that T. gondii can be used as an effective vaccine vector and future research should focus on exploring avirulent no cyst-forming strains of T. gondii as a live vaccine vector in animals.
format Online
Article
Text
id pubmed-3177786
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31777862011-09-22 Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts Zou, Jun Huang, Xiao-Xi Yin, Guang-Wen Ding, Ye Liu, Xian-Yong Wang, Heng Chen, Qi-Jun Suo, Xun Parasit Vectors Research BACKGROUND: Toxoplasma gondii has been shown to trigger strong cellular immune responses to heterologous antigens expressed by the parasite in the inbred mouse model [1]. We studied the immune response induced by T. gondii as an effective vaccine vector in chickens and rabbits. RESULTS: T. gondii RH strain was engineered to express the yellow fluorescent protein (YFP) in the cytoplasm. A subcutaneous injection of the transgenic T. gondii YFP in chickens afforded partial protection against the infection of transgenic E. tenella YFP. T. gondii YFP induced low levels of antibodies to YFP in chickens, suggesting that YFP specific cellular immune response was probably responsible for the protective immunity against E. tenella YFP infection. The measurement of T-cell response and IFN-γ production further confirmed that YFP specific Th1 mediated immune response was induced by T. gondii YFP in immunized chickens. The transgenic T. gondii stimulated significantly higher YFP specific IgG titers in rabbits than in chickens, suggesting greater immunogenicity in a T. gondii susceptible species than in a resistant species. Priming with T. gondii YFP and boosting with the recombinant YFP can induce a strong anti-YFP antibody response in both animal species. CONCLUSIONS: Our findings suggest that T. gondii can be used as an effective vaccine vector and future research should focus on exploring avirulent no cyst-forming strains of T. gondii as a live vaccine vector in animals. BioMed Central 2011-08-28 /pmc/articles/PMC3177786/ /pubmed/21871123 http://dx.doi.org/10.1186/1756-3305-4-168 Text en Copyright ©2011 Zou et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Zou, Jun
Huang, Xiao-Xi
Yin, Guang-Wen
Ding, Ye
Liu, Xian-Yong
Wang, Heng
Chen, Qi-Jun
Suo, Xun
Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts
title Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts
title_full Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts
title_fullStr Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts
title_full_unstemmed Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts
title_short Evaluation of Toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts
title_sort evaluation of toxoplasma gondii as a live vaccine vector in susceptible and resistant hosts
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3177786/
https://www.ncbi.nlm.nih.gov/pubmed/21871123
http://dx.doi.org/10.1186/1756-3305-4-168
work_keys_str_mv AT zoujun evaluationoftoxoplasmagondiiasalivevaccinevectorinsusceptibleandresistanthosts
AT huangxiaoxi evaluationoftoxoplasmagondiiasalivevaccinevectorinsusceptibleandresistanthosts
AT yinguangwen evaluationoftoxoplasmagondiiasalivevaccinevectorinsusceptibleandresistanthosts
AT dingye evaluationoftoxoplasmagondiiasalivevaccinevectorinsusceptibleandresistanthosts
AT liuxianyong evaluationoftoxoplasmagondiiasalivevaccinevectorinsusceptibleandresistanthosts
AT wangheng evaluationoftoxoplasmagondiiasalivevaccinevectorinsusceptibleandresistanthosts
AT chenqijun evaluationoftoxoplasmagondiiasalivevaccinevectorinsusceptibleandresistanthosts
AT suoxun evaluationoftoxoplasmagondiiasalivevaccinevectorinsusceptibleandresistanthosts